Form 4 for TRAW Traws Pharma, Inc.
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0001415889-21-005425 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-23 | 2021-11-19 | TRAW | OLER ABRAHAM N. | SVP CORP DEV, GEN COUNSEL | P - Purchase | $3.16 | +1,000 | 18.5K | +6% | +$3,160 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2021-11-19 | P | A | 1,000 | $3.16 | 18,514 | D | — | — | (F1) Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee |